Research Unit, University Hospital Nuestra Señora de Candelaria, Spain.
Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):37-46. doi: 10.1016/j.cytogfr.2012.01.004. Epub 2012 Feb 22.
In this work we summarizes the steps that allowed the identification of the fibroblast growth factor (FGF) 23/Klotho axis as the principal regulator of phosphate homeostasis, exerting actions on intestine, bone, parathyroid glands, and kidney. We review the not fully understood mechanisms of action of this axis on the regulation of mineral homeostasis and, in addition, we discuss its potential role in the pathophysiology of chronic kidney disease and the associated complications. We also reflect the actual tendency to consider the components of this system as better predictors of the pathological conditions frequently associated to mineral disorders, and review some recent studies linking these components to cardiovascular disease even in population without mineral disorders. Finally, we consider the numerous processes in which Klotho is involved, including anti-ageing and mineral control processes, independently of its functions as obligated-coreceptor for FGF23.
在这项工作中,我们总结了确定成纤维细胞生长因子 (FGF) 23/klotho 轴作为磷酸盐稳态主要调节剂的步骤,该轴对肠道、骨骼、甲状旁腺和肾脏发挥作用。我们回顾了该轴对矿物质稳态调节的作用机制尚不完全清楚,此外,我们还讨论了其在慢性肾脏病及其相关并发症病理生理学中的潜在作用。我们还反映了将该系统的成分作为与矿物质紊乱相关的病理状况更好的预测因子的实际趋势,并回顾了一些最近的研究,这些研究将这些成分与心血管疾病联系起来,即使在没有矿物质紊乱的人群中也是如此。最后,我们考虑了 klotho 参与的许多过程,包括抗衰老和矿物质控制过程,而这些过程与其作为 FGF23 必需核心受体的功能无关。